YUROBHomo sapiens (Human)Cancer cell line

AI Summary

No AI-generated summary available for this cell line.

Basic Information

Database IDCVCL_B486
SpeciesHomo sapiens (Human)
Tissue SourceAbdominal wall[UBERON:UBERON_0003697]

Disease Information

DiseaseCutaneous melanoma

DepMap Information

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleHRASp.Gln61Lys (c.181C>A)Unspecified-PubMed=26214590

Publications

Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas.

Schlessinger J., Lifton R.P., Halaban R.

Nat. Genet. 47:996-1002(2015).

Integrated analysis of tumor samples sheds light on tumor heterogeneity.

Kluger Y.

Yale J. Biol. Med. 85:347-361(2012).

Detecting copy number status and uncovering subclonal markers in heterogeneous tumor biopsies.

Xu F., Li P.-N., Halaban R., Kluger Y.

BMC Genomics 12:230.1-230.14(2011).

MicroRNA signatures differentiate melanoma subtypes.";

Krauthammer M., Tuck D., Slack F.J., Weidhaas J.B.

Cell Cycle 10:1845-1852(2011).

Phosphoproteomic screen identifies potential therapeutic targets in melanoma.

Muthusamy V., Bosenberg M.W., Krauthammer M., Halaban R., Stern D.F.

Mol. Cancer Res. 9:801-812(2011).

PLX4032, a selective BRAF(V600E) kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF melanoma cells.

Krauthammer M., McCusker J.P., Kluger Y., Sznol M.

Pigment Cell Melanoma Res. 23:190-200(2010).